21 juin 2009
Genzyme Plant Temporarily Closes; 2 Drugs' Supplies To Be Hurt
Vous trouverez des articles traitant du même sujet dans la catégorie "A propos des traitements et prise en charge".
Liens utiles à la fin des catégories.
Ghislaine SURREL
maladies-lysosomales-subscribe@yahoogroupes.fr
Tuesday June 16th, 2009 / 15h38
DOW JONES NEWSWIRES Genzyme Corp. (GENZ) said a Massachusetts plant will be out of commission for at least a month following the company's discovery of a virus over the weekend, with the drug maker expecting supplies of two drugs to become constrained.
Shares slumped 7.6% in recent premarket action to $51.33.
Investigators earlier this year found "significant objectionable conditions" during an inspection at the Allston Landing plant, outlining a number of deficiencies in the manufacturing process.
The Vesivirus 2117 virus strain, found in a bioreactor, hasn't been shown to cause human infection, but it is known to interfere with the growth of cells used to produce biologic drugs. It was likely introduced through a nutrient used in the manufacturing process, Genzyme said, and has confirmed the virus caused declines in cell productivity in two instances last year.
The drug firm, whose product portfolio focuses on rare genetic disorders as well as organ transplants, cancer and kidney disease, said it is collaborating with regulatory agencies to resume production and expects the plant to return to full operation by the end of July.
While assessing the business impact, Genzyme said current inventories for Gaucher treatment Cerezyme and Fabry's drug Fabrazyme aren't sufficient to meet projected global demand. The company doesn't know when or for how long Cerezyme supplies will be constrained but said Fabrazyme should be affected "for a limited time" starting in September.
-By Mike Barris, Dow Jones Newswires; 201-938-5658; mike.barris@dowjones.com;
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=nMZcyk2ZFp%2BAw7%2BkSZjUjQ%3D%3D. You can use this link on the day this article is published and the following day.
http://www.easybourse.com/bourse-actualite/marches/genzyme-plant-temporarily-closes-2-drugs-supplies-to-684869
________________________________________________________________________________________
Commentaires
Poster un commentaire
Rétroliens
URL pour faire un rétrolien vers ce message :
http://www.canalblog.com/cf/fe/tb/?bid=32604&pid=14163871
Liens vers des weblogs qui référencent ce message :
